Interchange Capital Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$517K Sell
1,636
-606
-27% -$216K 0.16% 137
2025
Q4
$734K Buy
2,242
+237
+12% +$75.2K 0.14% 144
2025
Q3
$566K Buy
2,005
+538
+37% +$156K 0.11% 163
2025
Q2
$410K Sell
1,467
-79
-5% -$22.4K 0.09% 173
2025
Q1
$482K Hold
1,546
0.13% 142
2024
Q4
$400K Sell
1,546
-24
-2% -$7.12K 0.14% 153
2024
Q3
$506K Sell
1,570
-68
-4% -$22.2K 0.18% 138
2024
Q2
$512K Buy
+1,638
New +$481K 0.19% 133
2023
Q4
Sell
-992
Closed -$259K 153
2023
Q3
$259K Sell
992
-530
-35% -$132K 0.21% 122
2023
Q2
$339K Sell
1,522
-2,132
-58% -$495K 0.26% 95
2023
Q1
$880K Buy
3,654
+1,796
+97% +$441K 0.48% 57
2022
Q4
$488K Sell
1,858
-183
-9% -$49.1K 0.5% 48
2022
Q3
$460K Buy
2,041
+19
+0.9% +$4.61K 0.5% 52
2022
Q2
$491K Sell
2,022
-53
-3% -$13K 0.55% 50
2022
Q1
$501K Sell
2,075
-232
-10% -$53.3K 0.51% 61
2021
Q4
$519K Buy
2,307
+804
+53% +$170K 0.52% 59
2021
Q3
$319K Sell
1,503
-47
-3% -$10.8K 0.53% 70
2021
Q2
$377K Sell
1,550
-1,297
-46% -$319K 0.58% 63
2021
Q1
$858K Sell
2,847
-577
-17% -$138K 0.47% 64
2020
Q4
$787K Buy
+3,424
New +$789K 0.43% 56

Other funds holding AMGN

Interchange Capital Partners's AMGN Position: Q1 2026 in Review

Interchange Capital Partners reduced its Amgen (AMGN) stake by 27% in Q1 2026, selling an estimated $216K and leaving 1,636 shares worth $517K. The position accounts for 0.16% of the portfolio, ranked #137.

Interchange Capital Partners first reported a position in AMGN in Q4 2020 and has held it in 20 quarters since. The position peaked at $880K in Q1 2023. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Interchange Capital Partners held 1,636 shares of Amgen worth $517K as of Q1 2026.
  • Interchange Capital Partners sold 606 Amgen shares in Q1 2026, an estimated $216K.
  • Amgen made up 0.16% of Interchange Capital Partners's portfolio in Q1 2026, its #137 holding.
  • Interchange Capital Partners first reported a position in Amgen in Q4 2020 and has held it in 20 quarters since.
  • Interchange Capital Partners's Amgen position peaked at $880K in Q1 2023.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Interchange Capital Partners's 13F filing for Q1 2026, filed 24 Apr 2026.